Story · Medicine & Biotech
Cristian Massacesi: Who Will Lead Bristol Myers Squibb’s Newly Unified R and D Organization?
2 outlets · first reported by OncoDaily on · latest · 47 hours of coverage · 2 countries
Cristian Massacesi, Executive Vice President, Chief Medical Officer and Head of Development at Bristol Myers Squibb, shared on LinkedIn: “I’m honored to share that starting January 1, 2027, I will (OncoDaily)
Coverage, in order
-
Cristian Massacesi: Who Will Lead Bristol Myers Squibb’s Newly Unified R and D Organization?Cristian Massacesi, Executive Vice President, Chief Medical Officer and Head of Development at Bristol Myers Squibb, shared on LinkedIn: “I’m honored to share that starting January 1, 2027, I will
-
Bristol Myers Squibb Unifies R&D Under Cristian Massacesi in Major Leadership RestructuringBristol Myers Squibb (BMS) is bringing its research and drug development operations together under one organization, appointing Cristian Massacesi, MD, to lead the combined R&D division effective January 1, 2027.
-
Bristol Myers Squibb Merges Research and Development Teams Under CMO Cristian MassacesiBengaluru : Bristol Myers Squibb said on Thursday it will combine its scientific and clinical expertise teams into an end-to-end research and development department under current Chief Medical Officer Cristian Massacesi, effective January 1, 2027. Current Chief Research Officer Robert Plenge will…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.